NS-229
N/A
Report date: 2026/04/08 15:33:03
NME
Base Information
Drug NameNS-229
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A
Develop Information
Active CompaniesNs Pharma IncNippon Shinyaku Co Ltd
Inactive CompaniesNeurosearch As
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A